ScienceMachine
ScienceMachine is a London-based AI platform company offering 'Sam,' an autonomous bioinformatics agent that automates end-to-end biomedical R&D workflows—from raw mass spectrometry and flow cytometry data through analysis, visualization, and report generation—for biotech and pharmaceutical researchers.
- Company typePrivate
- Founded2024
- HeadquartersNewark, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What ScienceMachine does
ScienceMachine is a London-based AI platform company that develops autonomous AI agents to automate end-to-end biomedical research and development workflows. Its flagship product, 'Sam,' is an autonomous bioinformatics agent that ingests raw laboratory data—including mass spectrometry and flow cytometry output—performs analysis and visualization, interprets results against referenced scientific literature, and produces reports and slides, with the ability to adapt to each lab's specific guidelines and preferences. The company serves biotech and pharmaceutical researchers as well as broader life sciences organizations, with named users including Flow Health Sciences, Inoviv, and Mitocholine.
ScienceMachine monetizes via a tiered SaaS subscription: a free tier for evaluation, a Pro plan for individual regular users (monthly or annual), a fixed-price Team plan with 10 seats and unlimited queries, and a custom Enterprise plan featuring tailored integrations, dedicated expert support, increased compute, enterprise-grade encryption, and multi-year contracts. Distribution combines a product-led growth motion through self-serve signup at app.sciencemachine.ai with a sales-led enterprise motion for larger deployments.
The company was founded in 2024 (per firmographic data), operates with 1-10 employees, and is headquartered in London, United Kingdom. In July 2025 it closed a $3.5 million pre-seed round led by Revent and Nucleus Capital (with Juniper and Opal Ventures also participating). Strategic commercial validation is in progress via a partnership with Artelo Biosciences on its FABP5 inhibitor program, and the company has co-developed the BixBench benchmark with FutureHouse and published BioML-bench to establish evaluation standards for AI agents in computational biology and biomedical machine learning. A claimed outcome of 90% reduction in biopharma experimentation is cited from a deployed customer case.
ScienceMachine firmographics
Firmographics- Name
- ScienceMachine
- Legal name
- ScienceMachine
- Website
- https://sciencemachine.ai
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ScienceMachine is a London-based AI platform company offering 'Sam,' an autonomous bioinformatics agent that automates end-to-end biomedical R&D workflows—from raw mass spectrometry and flow cytometry data through analysis, visualization, and report generation—for biotech and pharmaceutical researchers.
- Ownership category
- akta.pro rank
ScienceMachine industry classification
Industry- Product category
- AI Bioinformatics Software
- NAICS
- Software Publishers (513210), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Prepackaged Software (7372), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)
- akta.pro secondary industries
- Lab Automation, Instrument Control & Workflow Orchestration Software (HLAGAJAG), Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)
Keywords
Where ScienceMachine is headquartered
LocationHeadquarters
- HQ city
- Newark
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
ScienceMachine business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Revenue model
- SaaS Subscription (Tiered Plans): ScienceMachine generates revenue through tiered SaaS subscription plans: Free (limited usage), Pro (premium features for individuals), Team (fixed-price with shared access for research teams), and Enterprise (custom pricing for large organizations). Annual billing options available for Pro and Team plans, with custom limits and support for Enterprise deployments.
- Freemium Model: A free tier is offered to attract researchers with limited usage, serving as a lead generation and onboarding mechanism that converts users to paid Pro and Team plans as their needs scale.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | Free plan for exploring ScienceMachine with usage limits |
| Subscription | Monthly | Pro plan for regular users with higher query limits and premium features |
| Subscription | Monthly | Team plan for research teams with shared access and central billing |
| Subscription | Multi-year contract | Enterprise plan for organizations needing custom deployment and integrations |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels3 records
ScienceMachine product offering
Product offeringCore offering
ScienceMachine provides an autonomous AI bioinformatics agent platform (Sam) that automates end-to-end biomedical R&D workflows — from raw laboratory data ingestion through mass spectrometry and flow cytometry processing, analysis, and visualization, to automated report and slide generation. The platform is sold as a tiered SaaS subscription (Free, Pro, Team, Enterprise) and is purpose-built for biotech and pharmaceutical researchers who need to replace manual, bespoke data analysis with 24/7 agent-driven automation.
Product overview
ScienceMachine offers an AI platform for biomedical R&D comprising the core ScienceMachine Platform and its autonomous AI bioinformatics agent named Sam. The platform automates end-to-end workflows—from raw biomedical data processing (mass spectrometry, flow cytometry) through analysis and visualization to final report generation—powered by AI agents that adapt to specific research guidelines. Pricing tiers include Free, Pro, Team, and Enterprise plans with varying capabilities.
Differentiator
Problem solved
Functional benefit
Products and services
- ScienceMachine Platform (with Sam AI agent) An AI platform for biomedical research that automates end-to-end workflows from raw laboratory data to final reports. Powered by the autonomous AI bioinformatics agent Sam, it processes mass spectrometry and flow cytometry data, performs analysis and visualization, generates reports and slides, and interprets results against referenced scientific literature. Sold to biotech and pharmaceutical researchers and life sciences enterprises via Free, Pro, Team, and Enterprise SaaS subscriptions.
Quantifiable outcome
- 90% reduction in biopharma experimentation
Companies that use ScienceMachine
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
ScienceMachine technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature9 records
ScienceMachine partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Artelo BiosciencescoreScienceMachine entered a strategic partnership with Artelo Biosciences to accelerate development of its fatty acid-binding protein 5 (FABP5) inhibitor platform using cutting-edge AI agent technology. Since 2025, ScienceMachine has analyzed Artelo's large internal FABP datasets, identified potential proteins indicative of FABP5 target engagement in ART26.12-treated healthy volunteers, and revealed biological networks associated with disease severity and FABP signaling. The partnership aims to expand Artelo's pipeline potential, enhance R&D precision, and shorten the path to value creation.
- FutureHousecoreScienceMachine collaborated with FutureHouse to develop and publish BixBench, a comprehensive benchmark for LLM-based agents in computational biology. This partnership establishes evaluation standards for AI agents in biomedical research.
Scale indicators2 records
Recent moves6 records
Expansion highlights6 records
ScienceMachine competitors and assessment
Company assessmentBroad incumbents
- Dotmatics: Scientific informatics platform for R&D including data management, analysis, and visualization. Competes in the same biomedical data workflow space with established enterprise pharma customers.
- Benchling: Cloud platform for biotech R&D with LIMS, ELN, and workflow tools. Broad incumbent serving similar biotech/pharma researchers with a comprehensive data management suite rather than autonomous AI agents.
- Ginkgo Bioworks: Synthetic biology platform with extensive automated lab infrastructure. Competes for AI-driven biology R&D budgets and operates a similar automated lab paradigm that ScienceMachine's agent targets as customers.
- Recursion: Techbio company using AI and high-throughput biology for drug discovery. Represents both a competitor for AI-driven biology R&D dollars and a potential large customer for biomedical data analysis tooling.
- TetraScience: Scientific data cloud platform that ingests and harmonizes lab instrument data including mass spec and flow cytometry. Addresses similar data integration and analysis needs in life sciences R&D.
Emerging players
- Eikon Therapeutics: AI-driven biotech using live-cell imaging and automation for drug discovery. Competes in the AI-for-biomedical-research category and represents a sophisticated potential customer or competitor for automated lab data analysis.
- Cradle: AI platform for protein engineering and biologics design. Competes in the AI-for-biotech R&D space, focused on a different vertical (protein design) but addressing the same biotech AI tooling budget.
- Owkin: AI platform for biomedical research using federated learning. Targets similar pharma/biotech R&D customers and represents an adjacent AI-for-biology competitor with overlap in ML-driven scientific workflows.
- Insitro: AI-driven drug discovery company combining ML with biology. Competes for AI-enabled biomedical R&D budgets and represents the type of biotech customer ScienceMachine could serve.
Direct peers
- FutureHouse: AI research agent platform for scientific discovery. Direct peer that collaborated with ScienceMachine on the BixBench benchmark, building similar autonomous agents for biology research.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
ScienceMachine social profiles
Digital presenceScienceMachine financial estimates
Financial estimateRevenue estimate
Valuation estimate
ScienceMachine leadership team
Management profileNumber of profiles
ScienceMachine funding detail
Funding detailFunding overview
Funding rounds1 record
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ScienceMachine M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ScienceMachine
What does ScienceMachine do?
ScienceMachine provides an autonomous AI bioinformatics agent platform (Sam) that automates end-to-end biomedical R&D workflows — from raw laboratory data ingestion through mass spectrometry and flow cytometry processing, analysis, and visualization, to automated report and slide generation. The platform is sold as a tiered SaaS subscription (Free, Pro, Team, Enterprise) and is purpose-built for biotech and pharmaceutical researchers who need to replace manual, bespoke data analysis with 24/7 agent-driven automation.
When was ScienceMachine founded?
ScienceMachine was founded in 2024. It employs 11 to 50 people.
Where is ScienceMachine based?
ScienceMachine is headquartered in Newark, United States, in the North America region.
How does ScienceMachine make money?
Two revenue lines are on record. SaaS Subscription (Tiered Plans) is the primary driver. The others are freemium Model.
Who are ScienceMachine's main competitors?
Broad incumbents on record are Dotmatics, Benchling, Ginkgo Bioworks, Recursion and TetraScience. Emerging players are Eikon Therapeutics, Cradle, Owkin and Insitro. FutureHouse is listed as a direct peer.
Does ScienceMachine have an API?
No public API is recorded for ScienceMachine.
What industry is ScienceMachine in?
ScienceMachine's product category is AI Bioinformatics Software. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization, with a secondary code of HLAGAJAG, Lab Automation, Instrument Control & Workflow Orchestration Software. Its NAICS code is 513210 and its SIC code is 7372.